Marius C. Hoener

Best Publications

• Trace Amines and Their Receptors.

  Raul R Gainetdinov;Marius C Hoener;Mark D Berry

  381
  Citations

• TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.

  Florent G. Revel;Jean-Luc Moreau;Raul R. Gainetdinov;Amyaouch Bradaia

  373
  Citations

• Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity

  Lothar Lindemann;Claas Aiko Meyer;Karine Jeanneau;Amyaouch Bradaia

  364
  Citations

• Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

  Anna Rickli;Olivier D. Moning;Marius C. Hoener;Matthias E. Liechti

  356
  Citations

• A renaissance in trace amines inspired by a novel GPCR family

  Lothar Lindemann;Marius C. Hoener

  333
  Citations

• Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors.

  Lothar Lindemann;Martin Ebeling;Nicole A. Kratochwil;James R. Bunzow

  312
  Citations

• A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

  F G Revel;J-L Moreau;B Pouzet;R Mory

  295
  Citations

• The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system

  Amyaouch Bradaia;Gerhard Trube;Henri Stalder;Roger D. Norcross

  251
  Citations

• Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.

  L.D. Simmler;A. Rickli;M.C. Hoener;M.E. Liechti

  232
  Citations

• Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings.

  Evelyn Braungart;Manfred Gerlach;Peter Riederer;Ralf Baumeister

  228
  Citations

• Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).

  Anna Rickli;Dino Luethi;Julian Reinisch;Danièle Buchy

  223
  Citations

• Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges.

  Mark D. Berry;Raul R. Gainetdinov;Raul R. Gainetdinov;Marius C. Hoener;Mohammed Shahid

  223
  Citations

• Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones

  Anna Rickli;Marius C. Hoener;Matthias E. Liechti

  212
  Citations

• Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats.

  Damiana Leo;Ilya Sukhanov;Ilya Sukhanov;Francesca Zoratto;Placido Illiano

  210
  Citations

• Trace Amine-Associated Receptor 1 Partial Agonism Reveals Novel Paradigm for Neuropsychiatric Therapeutics

  Florent G. Revel;Jean-Luc Moreau;Raul R. Gainetdinov;Antonio Ferragud

  190
  Citations

• Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study

  Cédric M. Hysek;Linda D. Simmler;Valentina G. Nicola;Nerina Vischer

  184
  Citations

• The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans.

  CM Hysek;LD Simmler;M Ineichen;E Grouzmann

  183
  Citations

• Are there differences between the secretion characteristics of NGF and BDNF? Implications for the modulatory role of neurotrophins in activity-dependent neuronal plasticity.

  Oliver Griesbeck;Marco Canossa;Marco Canossa;Gabriele Campana;Gabriele Campana;Annette Gärtner

  148
  Citations

• Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors

  D. Leo;L. Mus;S. Espinoza;M.C. Hoener

  145
  Citations

• Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers.

  Anja Harmeier;Stefan Obermueller;Claas A. Meyer;Florent G. Revel

  144
  Citations